Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRDA compared with SKYE: revenue, margins and what each company keeps, and the suppliers and customers both name
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SKYE
Skye Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRDA
Entrada Therapeutics, Inc.
vs
SKYE
Skye Bioscience, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
TRDA
with
SKYE
No shared trading history for TRDA and SKYE.
Shared co-movers: not yet measured (SKYE).
TRDA, solid
SKYE, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
TRDA
Entrada Therapeutics, Inc.
Change
4.77
▼
−6.65%
Mkt cap
$176.6M
Revenue
$898,000
Q2 FY26
Revenue
$25M
FY25
SKYE
Skye Bioscience, Inc.
Change
1.33
▲
+0.76%
Regular session
Nov 3 '26
Mkt cap
$5.8M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
TRDA
Entrada Therapeutics, Inc.
vs
SKYE
Skye Bioscience, Inc.
4.77
▼
−6.65%
Price
1.33
▲
+0.76%
$176.6M
Mkt cap
$5.8M
Q2 FY26
$898,000
Revenue
—
FY25
$25M
Revenue
—
Change
Change
TRDA
4.77
▼
−6.65%
vs
SKYE
1.33
▲
+0.76%
Regular session
Nov 3 '26